AstraZeneca PLC (AZN)
91.51
+1.69
(+1.88%)
USD |
NASDAQ |
Dec 10, 16:00
91.56
+0.05
(+0.05%)
After-Hours: 20:00
AstraZeneca Market Cap: 283.72B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 97.28B |
| Amgen, Inc. | 169.83B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Autolus Therapeutics Plc | 407.20M |
| Moderna, Inc. | 11.34B |
Market Cap Related Metrics
| PE Ratio | 30.39 |
| PS Ratio | 4.919 |
| PEG Ratio | 0.6797 |
| Price to Book Value | 6.183 |
| Price to Free Cash Flow | 28.94 |
| Price | 91.51 |
| Earnings Yield | 3.29% |
| PEGY Ratio | 0.6546 |
| Operating PE Ratio | 22.48 |
| Normalized PE Ratio | 29.77 |